ETFs

ETF (UCITS compliant)

L&G Healthcare Breakthrough UCITS ETF

USD Accumulating ETF Class

ISINIE00BK5BC677

Price

TER0.49%

Fund aim

The L&G Healthcare Breakthrough UCITS ETF (the "ETF") aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”).

Fund snapshot

  • Long-term allocation

Long-term megatrend that we believe is radically transforming the way we live and work

  • High growth potential

Aims to capture the outsized growth potential of the healthcare technology industry

  • Leveraging industry expertise

An index tracking investment strategy that is supported by a team of healthcare technology experts

  • Does it have a sustainable objective?

The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices. Further information can be found in the Fund Supplement.

Fund facts

Fund size$77.9m
Base currencyUSD
Fund launch date2 Jul 2019
DomicileIreland
Share class launch2 Jul 2019
Replication methodPhysical - full replication
As at 1 Mar 2024

Benchmark

ROBO Global® Healthcare Technology and Innovation Index TR

Index description

ROBO Global® Healthcare Technology and Innovation Index TR

The Index aims to track the performance of a basket of companies that are actively engaged in the healthcare technology value-chain.

The index is comprised of companies which are publicly traded on various stock exchanges around the world that have a distinct portion of their business and revenue derived from the field of healthcare technologies, and the potential to grow within this space through innovation and/or market adoption of their products and/or services. Companies are included in the index receive a "HTEC Score"  comprised of factors representing (1)the levels of revenue the company receives from innovative healthcare technologies, (2) the levels of investment the firm makes in healthcare technologies, (3) the market and technology leadership of the firm within the universe.

A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently "liquid" ( a measure of how actively its shares are traded on a daily basis). Within the Index, companies are weighted according a modified HTEC-factor weighting scheme. The Index is rebalanced quarterly in March, June, September and December.

Index data

ProviderROBO Global®
Bloomberg codeHTECTR
Reuters code.HTECTR
TypeTotal Return
WebsiteGo to website

Performance

Performance for the USD Accumulating unit class in USD, launched on 02 July 2019. Source: Lipper. Performance assumes all ETF charges have been taken and that all income generated by the investments, after deduction of tax, remains in the ETF.
Past performance is not a reliable indicator of future performance. Markets could develop very differently in the future. It can help you to assess how the fund has been managed in the past. The tables and charts above shows the fund's performance as the percentage loss or gain per year over the last 10 years.
Share class launch date:02 Jul 2019
Benchmark:ROBO Global® Healthcare Technology and Innovation Index TR
Share class launch date:02 Jul 2019
Benchmark:ROBO Global® Healthcare Technology and Innovation Index TR
    Share class launch date:02 Jul 2019
    Benchmark:ROBO Global® Healthcare Technology and Innovation Index TR

    Performance scenarios

    The figures shown include all the costs of the product itself, but may not include all the costs that you pay to your advisor or distributor. The figures do not take into account your personal tax situation, which may also affect how much you get back.
    What you will get from this product depends on future market performance. Market developments in the future are uncertain and cannot be accurately predicted.
    The unfavourable, moderate, and favourable scenarios shown are illustrations using the worst, average, and best performance of the product with input from the over the last 10 years. Markets could develop very differently in the future.

    Example investment:10,000 USD

    Scenarios1 year(Recommended holding period) 5 years
    Minimum

    There is no minimum guaranteed return. You could lose some or all of your investment.

    Stress scenario
    What you might get back after costs1,430USD1,190USD
    Average return each year (%)-85.66USD-34.71USD
    Unfavourable scenario
    What you might get back after costs5,990USD5,810USD
    Average return each year (%)-40.13USD-10.31USD
    Moderate scenario
    What you might get back after costs11,940USD28,830USD
    Average return each year (%)19.38USD23.58USD
    Favourable scenario
    What you might get back after costs18,720USD52,770USD
    Average return each year (%)87.24USD39.47USD

    Portfolio breakdown

    Top 10 constituents20.2%
    Rest of Index79.8%
    No. of constituents in Index68

    Top 10 constituents (%)

    Azenta2.2
    Arrowhead Pharmaceuticals2.1
    Irhythm Technologies2.1
    Illumina2.1
    Moderna2.0
    Intuitive Surgical2.0
    Catalent2.0
    Revvity1.9
    Lonza Group1.9
    Stryker1.9

    Sector (%)

    Health Care
    97.0
    Information Technology
    1.3
    Consumer Staples
    0.9
    Materials
    0.8

    All data source LGIM unless otherwise stated. Totals may not sum to 100% due to rounding. The breakdowns shown relate to the Index. The ETF’s portfolio may deviate from the portfolio of the Index.

    Fund managers

    LGIM Index Fund Management Team headshot

    LGIM Index Fund Management Team

    The Index Fund Management team comprises 25 fund managers, supported by two analysts. Management oversight is provided by the Global Head of Index Funds. The team has average industry experience of 15 years, of which seven years has been at LGIM, and is focused on achieving the equally important objectives of close tracking and maximising returns.

    Sustainability

    SFDR categorisation

    The sustainable investment objective of the Fund is to provide exposure to the global healthcare technology industry. The Fund seeks to achieve its investment objective by tracking the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”). The Index is a reference benchmark that has been designated for the purpose of attaining the sustainable investment objective of the Fund.

    Literature

    Prices

    Pricing information

    Price time16:00 EST (NY)
    CurrencyUSD
    Monthly price history

    Listings and codes

    Listings

    ExchangeCurrencyTickerISINBloombergReutersListing dateTrading hours (local)
    Deutsche Börse Xetra
    EURXMLHIE00BK5BC677XMLH GYDOCT.DE10/09/201909:00 - 17:30
    London Stock Exchange
    GBPDOCGIE00BK5BC677DOCG LNDOCG.L02/07/201908:00 - 16:30
    London Stock Exchange
    USDDOCTIE00BK5BC677DOCT LNDOCT.L02/07/201908:00 - 16:30
    Borsa Italiana
    EURDOCTIE00BK5BC677DOCT IMLGDOCT.MI10/09/201909:00 - 17:30
    SIX Swiss Exchange
    CHFDOCTIE00BK5BC677DOCT SWDOCT.S05/06/202009:00 - 17:30

    Codes

    ISINIE00BK5BC677
    SEDOL-
    BloombergDOCT
    MEX-

    Dealing information

    IssuerLegal & General UCITS ETF Plc
    Depositary and TrusteeThe Bank of New York Mellon SA/NV, Dublin Branch
    Securities regulatorCentral Bank of Ireland

    Country registration

    This share class is registered for sale in the following countries:

    Austria
    Denmark
    Finland
    France
    Germany
    Ireland
    Italy
    Luxembourg
    Netherlands
    Norway
    Singapore*
    Spain
    Sweden
    Switzerland
    United Kingdom

    *The Fund is on the list of restricted collective investment schemes, but is not authorised or recognised by the Monetary Authority of Singapore (the “MAS”) and the Shares cannot be offered or marketed to retail clients.